Financhill
Buy
77

MNPR Quote, Financials, Valuation and Earnings

Last price:
$39.20
Seasonality move :
-13.19%
Day range:
$33.50 - $39.99
52-week range:
$1.55 - $39.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
41.95x
Volume:
102.1K
Avg. volume:
64K
1-year change:
2114.59%
Market cap:
$207.5M
Revenue:
--
EPS (TTM):
-$1.99

Earnings Data

Next earnings date for MNPR
Mar 28
2025
Most recent earnings per share
-$0.37
Beat by $0.80
(Nov 8/2024)
Consensus Estimate
-$1.17
(Nov 8/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MNPR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- -$0.57 --
03/28/2025 Q4 -- -- -- -$0.42 --
11/08/2024 Q3 -- -- -$0.37 -$1.17 $0.80
08/09/2024 Q2 -- -- -$0.50 -$0.47 -$0.03
05/09/2024 Q1 -- -- -$0.50 -$0.85 $0.35
03/28/2024 Q4 -- -- -$0.62 -$0.85 $0.23
11/09/2023 Q3 -- -- -$0.69 -$0.95 $0.26
08/11/2023 Q2 -- -- -$0.80 -$0.95 $0.15
05/11/2023 Q1 -- -- -$0.95 -$1.08 $0.13
03/23/2023 Q4 -- -- -$1.15 -$1.03 -$0.13
11/10/2022 Q3 -- -- -$0.95 -$1.08 $0.13
08/11/2022 Q2 -- -- -$1.10 -- --
05/12/2022 Q1 -- -- -$0.95 -- --
03/24/2022 Q4 -- -- -$1.05 -- --
11/12/2021 Q3 -- -- -$1.00 -- --
08/12/2021 Q2 -- -- -$0.85 -- --
05/13/2021 Q1 -- -- -$0.80 -- --
03/25/2021 Q4 -- -- -$0.95 -- --
11/12/2020 Q3 -- -- -$0.75 -- --
08/06/2020 Q2 -- -- -$0.70 -- --
05/07/2020 Q1 -- -- -$0.50 -- --
03/27/2020 Q4 -- -- -$0.57 -- --
09/30/2019 Q3 -- -- -$0.35 -- --
06/30/2019 Q2 -- -- -$0.43 -- --
03/31/2019 Q1 -- -- -$0.66 -- --
12/31/2018 Q4 -- -- -$0.43 -- --
09/30/2018 Q3 -- -- -$0.31 -- --
06/30/2018 Q2 -- -- -$0.36 -- --
03/31/2018 Q1 -- -- -$0.42 -- --
12/31/2017 Q4 -- -- -$0.34 -- --
09/30/2017 Q3 -- -- -$7.14 -- --
06/30/2017 Q2 -- -- -$0.28 -- --
03/31/2017 Q1 -- -- -$0.18 -- --

Monopar Therapeutics Earnings Questions

  • How Much did Monopar Therapeutics Generate in Revenue Last Quarter?

    Monopar Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Monopar Therapeutics Beat Earnings Last Quarter?

    Monopar Therapeutics announced earnings per share of -$0.37 which represents a beat of analyst forecast a -$1.17 per share.

  • Is Monopar Therapeutics Profitable?

    Monopar Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Monopar Therapeutics EPS Next Year?

    Monopar Therapeutics's earnings are forecast to decrease from -$3.05 per share to -$1.77 per share next year representing a decrease of -41.86%.

  • When is Monopar Therapeutics's Earnings Date?

    Monopar Therapeutics's next earnings date is March 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

1 Under the Radar Quantum Stock
1 Under the Radar Quantum Stock

Following comments by NVIDIA CEO Jensen Huang about the probable…

Is Mondelez Stock Overvalued?
Is Mondelez Stock Overvalued?

The company behind Oreo, Ritz, LU, Clif Bar, and Tate’s…

Where Will Morgan Stanley Stock Be in 10 Years?
Where Will Morgan Stanley Stock Be in 10 Years?

Morgan Stanley (NYSE:MS) share price has been on a tear,…

Stock Ideas

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 123x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Alerts

Buy
75
WNS alert for Jan 24

WNS (Holdings) [WNS] is up 23.57% over the past day.

Buy
77
MNPR alert for Jan 24

Monopar Therapeutics [MNPR] is up 16.42% over the past day.

Buy
75
HZO alert for Jan 24

MarineMax [HZO] is up 16.71% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock